|
Symbol
|
OSLRCH | RMBQ5V | KZEHDU | KZJVDU | RMBAIV | ACBBSQ | Z0AK9Z | Z0AKAZ | PLSRCH | ABYHTQ | ACGJTQ | BGLBIL | PUIRCH | KZXVDU | RMAXAV | Z0AXYZ | LAAHDU | Z0B18Z | RMA09V | RMBX5V |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Underlying
|
Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | Moderna Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | ASML Hldg. N.V. / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
19.08.2026 | 17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 30.06.2026 | 13.07.2026 | 13.07.2026 | 13.07.2026 | 21.07.2026 | 03.09.2026 | 28.08.2026 | 17.09.2026 | 08.09.2026 | 12.10.2026 | 16.10.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 |
| Bid | 35.060 | 44.200 | 43.550 | 41.300 | 55.90 | 51.98 | - | - | 49.980 | 56.17 | 49.510 | 67.38 | 53.04 | 48.950 | 74.60 | - | 75.30 | - | 67.40 | 55.30 |
| Ask | - | - | 44.550 | - | - | - | - | - | - | - | - | - | - | 49.950 | - | - | 76.30 | - | - | - |